AGP Executive Report
Last update: 9 hours agoCancer Care: Mankind Pharma will acquire a 70% stake in Belgian biotech Armed Cell Therapeutics for €48 million through its Dutch subsidiary. The company is developing CAR-T therapies for lymphoma and small-cell lung cancer. Infectious Disease: The Netherlands has recorded five new West Nile virus cases, with the country’s death toll still at 10, as Europe reports its worst season on record: 1,715 infections and 130 deaths. Screening Research: A Dutch-Belgian study found that lung cancers detected by low-dose CT had features linked to adenocarcinoma, including smaller size and pleural attachment. Women’s Health: Two-thirds of women in the Netherlands say they sometimes feel unheard by healthcare providers. Separately, the country plans to end the 13-week pregnancy ultrasound from 2028.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.